Home » Stocks » Forte Biosciences

Forte Biosciences, Inc. (FBRX)

Stock Price: $33.27 USD -1.24 (-3.59%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed
After-hours: $35.50 +2.23 (6.70%) Oct 26, 4:26 PM

Stock Price Chart

Key Info

Market Cap 53.05M
Revenue (ttm) 18,000
Net Income (ttm) -74.36M
Shares Out 1.59M
EPS (ttm) -34.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $33.27
Previous Close $34.51
Change ($) -1.24
Change (%) -3.59%
Day's Open 33.93
Day's Range 33.26 - 35.85
Day's Volume 20,550
52-Week Range 6.33 - 53.99

More Stats

Market Cap 53.05M
Enterprise Value 25.30M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 1.59M
Float 1.48M
EPS (basic) -34.27
EPS (diluted) -34.27
FCF / Share -8.22
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 244,686
Short Ratio 2.22
Short % of Float 16.58%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2,947.33
PB Ratio 15.19
Revenue 18,000
Operating Income -71.28M
Net Income -74.36M
Free Cash Flow -30.01M
Net Cash 27.75M
Net Cash / Share 17.40
Gross Margin 100.00%
Operating Margin -395,977.78%
Profit Margin -413,105.60%
FCF Margin -166,722.22%
ROA -39.91%
ROE -76.28%
ROIC -771.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(155.49% upside)
Current: $33.27
Target: 85.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-99.8%43890.24%-16.33%-3.92%-
Gross Profit0.0418.
Operating Income-61.51-45.85-37.63-31.69-22.95
Net Income-63.52-48.96-38.93-33.48-23.06
Shares Outstanding1.581.340.970.150.15
Earnings Per Share-40.35-36.60-39.90-228.29-158.54
Operating Cash Flow-59.24-34.47-31.13-29.54-21.04
Capital Expenditures0.01-1.97-0.64-0.53-0.22
Free Cash Flow-59.23-36.44-31.77-30.06-21.26
Cash & Equivalents6.9496.0988.7331.2558.91
Total Debt-26.2010.8320.9817.47
Net Cash / Debt6.9469.8977.9010.2741.44
Book Value-4.7758.1571.08-124-92.33
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Forte Biosciences, Inc.
Country United States
Employees 5
CEO Paul A. Wagner

Stock Information

Ticker Symbol FBRX
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: FBRX


Forte Biosciences operates as a clinical-stage dermatology company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company is based in Torrance, California.